Literature DB >> 30097893

Medical Prophylaxis of Post-Surgical Crohn's Disease Recurrence: Towards Timely Anti-TNF Therapy.

Adam C Fields1, Nelya Melnitchouk2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30097893     DOI： 10.1007/s10620-018-5236-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  9 in total

1.  Infliximab prevents Crohn's disease recurrence after ileal resection.

Authors:  Miguel Regueiro; Wolfgang Schraut; Leonard Baidoo; Kevin E Kip; Antonia R Sepulveda; Marilyn Pesci; Janet Harrison; Scott E Plevy
Journal:  Gastroenterology       Date:  2008-10-31       Impact factor: 22.682

Review 2.  American Gastroenterological Association Institute Guideline on the Management of Crohn's Disease After Surgical Resection.

Authors:  Geoffrey C Nguyen; Edward V Loftus; Ikuo Hirano; Yngve Falck-Ytter; Siddharth Singh; Shahnaz Sultan
Journal:  Gastroenterology       Date:  2016-11-10       Impact factor: 22.682

3.  American Gastroenterological Association Institute Technical Review on the Management of Crohn's Disease After Surgical Resection.

Authors:  Miguel Regueiro; Fernando Velayos; Julia B Greer; Christina Bougatsos; Roger Chou; Shahnaz Sultan; Siddharth Singh
Journal:  Gastroenterology       Date:  2016-11-10       Impact factor: 22.682

4.  Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.

Authors:  Edoardo Savarino; Giorgia Bodini; Pietro Dulbecco; Lorenzo Assandri; Linda Bruzzone; Fabrizio Mazza; Anna Chiara Frigo; Valentina Fazio; Elisa Marabotto; Vincenzo Savarino
Journal:  Am J Gastroenterol       Date:  2013-09-10       Impact factor: 10.864

5.  Delays in Initiating Post-operative Prophylactic Biologic Therapy Are Common Among Crohn's Disease Patients.

Authors:  Shirley Cohen-Mekelburg; Stephanie Gold; Yecheskel Schneider; Madison Dennis; Clara Oromendia; Heather Yeo; Fabrizio Michelassi; Ellen Scherl; Adam Steinlauf
Journal:  Dig Dis Sci       Date:  2018-06-07       Impact factor: 3.199

6.  Variation in Care of Inflammatory Bowel Diseases Patients in Crohn's and Colitis Foundation of America Partners: Role of Gastroenterologist Practice Setting in Disease Outcomes and Quality Process Measures.

Authors:  Kimberly N Weaver; Michael D Kappelman; Robert S Sandler; Christopher F Martin; Wenli Chen; Kristen Anton; Millie D Long
Journal:  Inflamm Bowel Dis       Date:  2016-11       Impact factor: 5.325

7.  Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study.

Authors:  Alessandro Armuzzi; Carla Felice; Alfredo Papa; Manuela Marzo; Daniela Pugliese; Gianluca Andrisani; Francesco Federico; Italo De Vitis; Gian Lodovico Rapaccini; Luisa Guidi
Journal:  J Crohns Colitis       Date:  2013-06-27       Impact factor: 9.071

Review 8.  Biologics for the prevention of postoperative Crohn's disease recurrence: A systematic review and meta-analysis.

Authors:  Ye Zhao; Teng Ma; Yan-Fang Chen; Xiao-Yan He; Li-Hua Ren; Jian Chen; Lin Fang; Jie-Wen Su; Hong-Jie Zhang; Rui-Hua Shi
Journal:  Clin Res Hepatol Gastroenterol       Date:  2015-05-07       Impact factor: 2.947

9.  Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Disease.

Authors:  Amir Rumman; Roberto Candia; Justina J Sam; Kenneth Croitoru; Mark S Silverberg; A Hillary Steinhart; Geoffrey C Nguyen
Journal:  Can J Gastroenterol Hepatol       Date:  2017-01-23
  9 in total
  1 in total

Review 1.  Surgical Management of Small Bowel Crohn's Disease.

Authors:  Pramodh Chandrasinghe
Journal:  Front Surg       Date:  2022-04-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.